Cardinal Health Inc (CAH) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
Total Revenue Chart for Cardinal Health Inc
Cardinal Health Inc (CAH) revenue for FY2026 was USD 254.2B, a 14.2% change from FY2025. Cardinal Health Inc's revenue grew from USD 429.0M in 1986 to USD 254.2B in 2026 (59165.3% over 40 years). Earnings per share grew from USD 1.50 in 2000 to USD 6.45 in 2025 (331.1%). Revenue compound annual growth rate: 5-year CAGR of 9.4%, 10-year CAGR of 7.7%, 20-year CAGR of 6.0%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $54.69B
- Implied Share Price
- $235.17
- Enterprise Value
- $58.72B
- Revenue (TTM)
- $254.25B
- EBITDA
- $4.24B
- Profit Margin
- 0.67%
- Trailing P/E
- 32.57
- Forward P/E
- 19.12
- Price/Book (MRQ)
- 16.07
- Price/Sales (TTM)
- 0.22
- EV/EBITDA
- 16.88
- EV/Revenue
- 0.23
- Dividend Yield
- 0.89%
- Book Value
- $-12.37
- Free Cash Flow (FY2026)
- $4.53B
- Free Cash Flow Yield
- 8.27%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.